 |
Teva’s $40bn bid 'to transform generic drug sector'Teva Pharmaceutical Industries’ recent $40-billion bid to purchase Netherlands-based Mylan has the potential to transform the generic drugs arena, said an analyst with research and consulting firm GlobalData. Mylan had made More… |
 |
Glaxo enters branded generics marketGlaxoSmithKline, the world's second largest drugmaker, took a bold step in the branded generics marketplace via an alliance with South Africa's Aspen Pharmacare Holdings. The move is the latest sign of Glaxo diversifying the focus of its b More… |
